DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Arcturus Therapeutics
Arcturus Therapeutics
PDF Version
ARCTURUS THERAPEUTICS HOLDINGS INC. (Exact Name of Registrant As Specified in Its Charter)
Building the Next Generation of RNA Medicines
COVID-19 and Influenza Viral Vector Vaccines
An Update on Self-Amplifying Mrna Vaccine Development
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Positive Clinical Updates
Fidelity® Nasdaq Composite Index® Fund
List of COVID-19 Vaccine Candidates
ARCTURUS THERAPEUTICS HOLDINGS INC. (Exact Name of Registrant As Specified in Its Charter)
Recipharm Signs Agreement with Arcturus Therapeutics to Support the Manufacture of LUNAR®-COV19 (ARCT-021) Vaccine Candidate
ARCTURUS THERAPEUTICS HOLDINGS INC. (Exact Name of Registrant As Specified in Its Charter)
LUNAR-FLU Flu Vaccine
Arcturus Announces Approval of a Clinical Trial Application To
Arcturus—A Clinical-Stage Mrna Therapeutics and Vaccines Company
Interview with Arcturus Therapeutics
Arcturus Therapeutics Appoints Lance Kurata As Chief Legal Officer
Nanomaterial Delivery Systems for Mrna Vaccines
Guggenheim Covid-19 Current State of Play
Top View
Vaccine Candidate in the United States
Fidelity® Nasdaq Composite Index Tracking Stock (To Be Renamed Fidelity® Nasdaq Composite Index ETF Effective January 29, 2021)